[Pathogenesis and therapeutic targets of diabetic microvascular complications].
Li
Hong
H
Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. lihong@mail.hz.zj.cn
D000449:Aldehyde Reductase / Q000502:physiology; D016207:Cytokines / Q000096:biosynthesis; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000628:therapy*; D017127:Glycation End Products, Advanced / Q000502:physiology; D006801:Humans; D018384:Oxidative Stress; D011493:Protein Kinase C / Q000502:physiology
D016207:Cytokines; D017127:Glycation End Products, Advanced; D000449:Aldehyde Reductase; D011493:Protein Kinase C